Google
CMPS — COMPASS PATHWAYS PLC (Healthcare >> Medical Care Facilities)
CMPS FAQ
What is CMPS's P/E ratio?
COMPASS PATHWAYS PLC (CMPS) currently trades at a P/E ratio of 19.58.
What is CMPS's ROE?
COMPASS PATHWAYS PLC reports a Return on Equity (ROE) of -54.78%.
What is CMPS's dividend yield?
COMPASS PATHWAYS PLC offers a dividend yield of 0.00%.
What is CMPS's Deepscope Quality Score?
Deepscope rates CMPS's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CMPS?
Deepscope's AI Timing Score for CMPS is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CMPS belong to?
COMPASS PATHWAYS PLC is classified under the Healthcare >> Medical Care Facilities sector on the NASDAQ exchange.
|
USD 12.11
Price
-0.94
(-7.20%)
Day Change
|
|
|---|
CMPS, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 85 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 12.11 |
| PBV / Sector |
5.46 / 327.78
|
| Earning Per Share | -1.22 |
| PE / Sector |
19.58 / 19.65
|
| PEG or PE/Growth / Sector |
1.45 / -0.57
|
| Average 1M Daily Value |
50.89 M
|
| Average 1W Daily Value |
65.19 M
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:29 |
| Symbol | CMPS |
| Name | COMPASS PATHWAYS PLC |
| Sector | Healthcare >> Medical Care Facilities |
| Market | NASDAQ |
| Listed Shares | 134.95 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,782.68 / 6,090.85 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ
Phone: 44 716 6766461
Website: https://compasspathways.com
Employees: 156
Description: COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
